{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:07:25Z","timestamp":1794276445355,"version":"4.9.0"},"reference-count":32,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The circulating metabolome incorporates multiple levels of biological interactions and is an emerging field for biomarker discovery. However, few studies have linked metabolite levels with quantitative neurologic function assessments in people with multiple sclerosis (pwMS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>We quantified metabolomic differences between pwMS and healthy controls (HCs) and assessed the association of metabolites with disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We profiled 517 metabolites using liquid chromatography-mass spectrometry (Biocrates Inc.) for participants from the MS Partners Advancing Technology and Health Solutions (MS PATHS). We conducted a multicenter cross-sectional study and applied linear regression to assess the association between metabolites and neurological function measures in multiple sclerosis (MS), including walking speed, manual dexterity, and processing speed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 1010 participants (837 MS; 71.2% relapsing-remitting MS; 173 HC; mean age: 44.5 (standard deviation (SD): 11.4); 73.9% female; 12.7% non-white), pwMS showed decreased levels of phosphatidylcholines (PCs) and different amino acids (AAs) but increased triglycerides (TGs). Metabolites showed an association with worse neurologic function; for instance, a 1-SD decrease in\n                      <jats:italic>PC aa C36:6<\/jats:italic>\n                      was associated with 21.36% (95% confidence interval (CI): 11.07\u201330.46;\n                      <jats:italic>p<\/jats:italic>\n                      = 1.35E\u221204) slower walking speed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This large study identified lipid alterations linked to MS severity. Future longitudinal studies will evaluate if these metabolite levels predict MS outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13524585251325468","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T02:06:21Z","timestamp":1743127581000},"page":"433-443","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":13,"title":["Metabolic and lipid alterations in multiple sclerosis linked to disease severity"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2294-171X","authenticated-orcid":false,"given":"Rezvan","family":"Noroozi","sequence":"first","affiliation":[{"name":"Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hsin","family":"Tsai","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketian","family":"Yu","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9996-9812","authenticated-orcid":false,"given":"Paola","family":"Bronson","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karunakar","family":"Samuel","sequence":"additional","affiliation":[{"name":"Department of Neuroimmunology, School of Medicine and Dentistry, University of Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kien","family":"Trinh","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Wei","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Tsai","sequence":"additional","affiliation":[{"name":"Biogen, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-1359","authenticated-orcid":false,"given":"Farren BS","family":"Briggs","sequence":"additional","affiliation":[{"name":"Public Health Sciences, Miller School of Medicine, University of Miami, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7947-9418","authenticated-orcid":false,"given":"Pavan","family":"Bhargava","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3137-0322","authenticated-orcid":false,"given":"Kathryn C","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA"},{"name":"Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1401483"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007035"},{"key":"e_1_3_2_4_2","article-title":"Peer reviewed: The prevalence of multiple sclerosis in 3 US communities","volume":"7","author":"Williamson DM","year":"2010","unstructured":"Williamson DM, Noonan CW, Henry JP, et al. Peer reviewed: The prevalence of multiple sclerosis in 3 US communities. Prevent Chron Dis 2010; 7: A12.","journal-title":"Prevent Chron Dis"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100424"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109225"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00632"},{"key":"e_1_3_2_8_2","article-title":"The Multiple Sclerosis Performance Test (MSPT): An iPad-based disability assessment tool","volume":"88","author":"Rudick RA","year":"2014","unstructured":"Rudick RA, Miller D, Bethoux F, et al. The Multiple Sclerosis Performance Test (MSPT): An iPad-based disability assessment tool. JOVE: J Visual Exp 2014; 88: e51318.","journal-title":"JOVE: J Visual Exp"},{"key":"e_1_3_2_9_2","unstructured":"Adam MG Limonciel A Ustaszewski B. Validation and application of a unique reference database for metabolomics: The Quantitative Metabolomics Database (QMDB). https:\/\/biocrates.com\/wp-content\/uploads\/2022\/11\/Whitepaper_QMBD.pdf"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108672"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2011.06.023"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231171517"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102189"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282x20190122"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-127"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/foods12203730"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.101981"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514533162"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109056"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00120.2016"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2013.05.018"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.03.006"},{"key":"e_1_3_2_25_2","first-page":"9010937","article-title":"Changes in amino acid and acylcarnitine plasma profiles for distinguishing patients with multiple sclerosis from healthy controls","volume":"2020","author":"Kasakin MF","year":"2020","unstructured":"Kasakin MF, Rogachev AD, Predtechenskaya EV, et al. Changes in amino acid and acylcarnitine plasma profiles for distinguishing patients with multiple sclerosis from healthy controls. Mult Scler Int 2020; 2020: 9010937.","journal-title":"Mult Scler Int"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-022-03162-4"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21206"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.5603\/PJNNS.a2023.0054"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146589"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000321"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1039\/C9MD00253G"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100246"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-016-2057-z"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585251325468","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13524585251325468","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13524585251325468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:17:56Z","timestamp":1777695476000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13524585251325468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1177\/13524585251325468"],"URL":"https:\/\/doi.org\/10.1177\/13524585251325468","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}